These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 1516416)
1. Small airways dysfunction in systemic sclerosis. A controlled study. Kostopoulos C; Rassidakis A; Sfikakis PP; Antoniades L; Mavrikakis M Chest; 1992 Sep; 102(3):875-81. PubMed ID: 1516416 [TBL] [Abstract][Full Text] [Related]
2. Pulmonary function in patients with systemic sclerosis. Spagnolatti L; Zoia MC; Volpini E; Convertino G; Fulgoni P; Corsico A; Vitulo P; Cerveri I Monaldi Arch Chest Dis; 1997 Feb; 52(1):4-8. PubMed ID: 9151512 [TBL] [Abstract][Full Text] [Related]
3. Clinical and demographic predictors of loss of pulmonary function in systemic sclerosis. Peters-Golden M; Wise RA; Schneider P; Hochberg M; Stevens MB; Wigley F Medicine (Baltimore); 1984 Jul; 63(4):221-31. PubMed ID: 6738343 [TBL] [Abstract][Full Text] [Related]
4. Interrelationships between pulmonary and extrapulmonary involvement in systemic sclerosis. A longitudinal analysis. Tashkin DP; Clements PJ; Wright RS; Gong H; Simmons MS; Lachenbruch PA; Furst DE Chest; 1994 Feb; 105(2):489-95. PubMed ID: 8306752 [TBL] [Abstract][Full Text] [Related]
5. Induced Sputum Analysis in Subjects With Systemic Sclerosis. Litinsky I; Fireman E; Paran D; Polachek A; Broide A; Sharabi A; Anouk M; Elkayam O Respir Care; 2016 Oct; 61(10):1369-73. PubMed ID: 27274093 [TBL] [Abstract][Full Text] [Related]
6. Pulmonary findings in patients with primary Sjögren's syndrome. Lahdensuo A; Korpela M Chest; 1995 Aug; 108(2):316-9. PubMed ID: 7634859 [TBL] [Abstract][Full Text] [Related]
7. HRCT and pulmonary function tests in monitoring of lung involvement in juvenile systemic sclerosis. Panigada S; Ravelli A; Silvestri M; Granata C; Magni-Manzoni S; Cerveri I; Dore R; Tomà P; Martini A; Rossi GA; Sacco O Pediatr Pulmonol; 2009 Dec; 44(12):1226-34. PubMed ID: 19911363 [TBL] [Abstract][Full Text] [Related]
8. Lung involvement in systemic sclerosis. Silver RM; Miller KS Rheum Dis Clin North Am; 1990 Feb; 16(1):199-216. PubMed ID: 2406808 [TBL] [Abstract][Full Text] [Related]
9. Small airways in progressive systemic sclerosis (PSS). Bjerke RD; Tashkin DP; Clements PJ; Chopra SK; Gong H; Bein M Am J Med; 1979 Feb; 66(2):201-9. PubMed ID: 425965 [TBL] [Abstract][Full Text] [Related]
10. Correlation of the degree of dyspnea with health-related quality of life, functional abilities, and diffusing capacity for carbon monoxide in patients with systemic sclerosis and active alveolitis: results from the Scleroderma Lung Study. Khanna D; Clements PJ; Furst DE; Chon Y; Elashoff R; Roth MD; Sterz MG; Chung J; FitzGerald JD; Seibold JR; Varga J; Theodore A; Wigley FM; Silver RM; Steen VD; Mayes MD; Connolly MK; Fessler BJ; Rothfield NF; Mubarak K; Molitor J; Tashkin DP; Arthritis Rheum; 2005 Feb; 52(2):592-600. PubMed ID: 15692967 [TBL] [Abstract][Full Text] [Related]
11. Exercise tolerance in systemic sclerosis patients without pulmonary impairment: correlation with clinical variables. Rosato E; Romaniello A; Magrì D; Bonini M; Sardo L; Gigante A; Quarta S; Digiulio MA; Viola G; Di Paolo M; Jacoangeli F; Baiocchi P; Salsano F; Palange P Clin Exp Rheumatol; 2014; 32(6 Suppl 86):S-103-8. PubMed ID: 25372795 [TBL] [Abstract][Full Text] [Related]
12. Predictors of exercise-induced oxygen desaturation in systemic sclerosis patients with interstitial lung disease. Someya F; Mugii N; Hasegawa M; Yahata T; Nakagawa T Respir Care; 2014 Jan; 59(1):75-80. PubMed ID: 23764864 [TBL] [Abstract][Full Text] [Related]
13. Enalapril (10 mg/day) in systemic sclerosis. One year, double blind, randomised study (ESS-1): pulmonary substudy--effects of three month treatment. Ostrowski S; Chibowska M; Biłan A; Palusiński R; Weglarz J; Makaruk B; Krasowska D; Hanzlik J Adv Exp Med Biol; 1999; 455():289-93. PubMed ID: 10599357 [TBL] [Abstract][Full Text] [Related]
14. Evidence for oesophageal and anorectal involvement in very early systemic sclerosis (VEDOSS): report from a single VEDOSS/EUSTAR centre. Lepri G; Guiducci S; Bellando-Randone S; Giani I; Bruni C; Blagojevic J; Carnesecchi G; Radicati A; Pucciani F; Marco MC Ann Rheum Dis; 2015 Jan; 74(1):124-8. PubMed ID: 24130266 [TBL] [Abstract][Full Text] [Related]
15. Clinical and sociodemographic features of Puerto Ricans with systemic sclerosis. Ríos G; Mayor AM Ethn Dis; 2010; 20(1 Suppl 1):S1-185-9. PubMed ID: 20521412 [TBL] [Abstract][Full Text] [Related]
16. Antinuclear antibodies associated with pulmonary involvement in systemic sclerosis. Martinez-Cordero E Chest; 1989 Oct; 96(4):960-1. PubMed ID: 2791706 [No Abstract] [Full Text] [Related]
17. Characterization of pulmonary function impairments in patients with mucopolysaccharidoses--changes with age and treatment. Lin SP; Shih SC; Chuang CK; Lee KS; Chen MR; Niu DM; Chiu PC; Lin SJ; Lin HY Pediatr Pulmonol; 2014 Mar; 49(3):277-84. PubMed ID: 23401495 [TBL] [Abstract][Full Text] [Related]
18. Systemic sclerosis, small airways dysfunction, and bronchial hyperreactivity. Lombardi C; Spedini C Chest; 1994 Jun; 105(6):1922-3. PubMed ID: 8205928 [No Abstract] [Full Text] [Related]
19. Assessments of pulmonary involvement in patients with systemic sclerosis. Gohari Moghadam K; Gharibdoost F; Parastandechehr G; Salehian P Arch Iran Med; 2011 Jan; 14(1):22-6. PubMed ID: 21194257 [TBL] [Abstract][Full Text] [Related]
20. Scleroderma lung: initial forced vital capacity as predictor of pulmonary function decline. Plastiras SC; Karadimitrakis SP; Ziakas PD; Vlachoyiannopoulos PG; Moutsopoulos HM; Tzelepis GE Arthritis Rheum; 2006 Aug; 55(4):598-602. PubMed ID: 16874782 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]